Legis invests in litigation

Our team works across the intersection of litigation and the international finance markets. We work with law firms seeking to finance their cases - whether working on a contingent fee or supporting the client of the law firm.

Our Markets

 

Law Firms

Offer alternatives to your clients.  Fund operating expenses and case disbursements on a non-recourse basis.  Use insurance with your existing credit lines to compete with litigation funders.  Free up capital invested in contingent fees.

Investors

Get exposure to the litigation funding market: esoteric and non-systemic returns.  Portfolio valuations and support on existing investments.  Syndication opportunities.

 

Litigation Funders

Get access to high quality international deal flow.  Use insurance to offset your portfolio risk.  Syndicate existing investments and make more capital available for new investments.  Increase your deal size by syndicating new deals.

Corporations

Finance existing cases.  Use litigation finance to move the cost of litigation off the P/L.  Value existing litigation. Sell participations to release cash.


Expert Investors

 

Investing in Litigation

The Legis team has been investing in litigation for over 13 years – longer than most.  We have dedicated capital and experience in most sectors of the market – in the UK, Europe, US and offshore. We also understand that not all litigation risk is the same; and pricing needs to reflect this.

Relationships

Good investing and litigation funding is about building long-term relationships with law firms, companies and investors.  We value trust and the ability to work alongside our partners in situations which require efficient and effective decision-making.

Portfolio Management

Litigation is an esoteric risk; and each investment typically involves discrete risks.  The Legis team has broad litigation as well as financial experience and understands the complexities of managing a portfolio of litigation – particularly the need to balance short term turnover with medium-term risk — and avoid the tail risk that typifies many of the funds today.